Olopatadine Administration and Efficacy

Formulations and Dosing Instructions

The American Academy of Otolaryngology-Head and Neck Surgery recommends olopatadine nasal spray (0.6%) for seasonal allergic rhinitis in patients 6 years and older, with dosing instructions of 1 spray in each nostril twice daily for ages 6-11 years and 2 sprays in each nostril twice daily for ages 12 years and older 1
The Journal of Allergy and Clinical Immunology reports that olopatadine ophthalmic solution (0.1%) is typically administered twice daily 2

Proper technique for ophthalmic use involves tilting the head back slightly, pulling down the lower eyelid, and placing the drop in the pocket without touching the eye or eyelid with the dropper tip, as recommended by Praxis Medical Insights 3
For nasal use, patients should clear their nasal passages before administration and shake the bottle gently before use, according to the American Academy of Otolaryngology-Head and Neck Surgery 1

Olopatadine has dual action as both an antihistamine and mast cell stabilizer, with an onset of action within 30 minutes for ophthalmic use, as reported by the Journal of Allergy and Clinical Immunology 2
The American Academy of Otolaryngology-Head and Neck Surgery states that olopatadine nasal spray provides targeted delivery to nasal tissues while limiting systemic effects, and is more effective for nasal congestion than oral antihistamines 1

Common side effects of olopatadine nasal spray include bitter taste (12.8%), epistaxis, headache, and somnolence (0.9%), as reported by the American Academy of Otolaryngology-Head and Neck Surgery and the Journal of Allergy and Clinical Immunology 1, 4
Patients should be monitored for sedation, especially when initiating therapy, as recommended by the American Academy of Otolaryngology-Head and Neck Surgery and the Journal of Allergy and Clinical Immunology 1, 4

Intranasal antihistamines like olopatadine show benefit even in patients who fail oral antihistamine treatment, according to the American Academy of Otolaryngology-Head and Neck Surgery 1
Patients with taste aversion to intranasal antihistamines may benefit from a trial of a different formulation, as suggested by the American Academy of Otolaryngology-Head and Neck Surgery 1

The American Academy of Allergy, Asthma, and Immunology recommends olopatadine 0.1% ophthalmic solution, which is FDA-approved and requires prescription, dosed as one drop in each affected eye twice daily 5
The American Academy of Allergy, Asthma, and Immunology recommends olopatadine 0.6% nasal spray (Patanase), which is the only intranasal formulation available, requiring prescription, with dosing for ages ≥12 years: 2 sprays per nostril twice daily 5

The United States FDA requires a prescription for all olopatadine formulations, with no over-the-counter (OTC) versions available, as stated by the American Academy of Allergy, Asthma, and Immunology 5, 6
The American Academy of Allergy, Asthma, and Immunology distinguishes olopatadine from some other antihistamine eye drops like ketotifen (Zaditor, Alaway), which are available OTC, and warns against confusing olopatadine with OTC antihistamine/vasoconstrictor combinations (like naphazoline/pheniramine) that are available without prescription 6